drugset
drugset / Trial / NCT05718921

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

NCT05718921 ↗

Phase 1 Completed 54 enrolled Hangzhou Yirui Pharmaceutical Technology Co., Ltd
RandomizedSequentialTriple-blindTreatment

Summary

This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in healthy adult subjects.

Timeline

Start
2023-04-08
Primary completion
2023-08-14
Completion
2023-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject YR001 Unknown — Topical

Indications

atopic eczema psoriasis